Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > TLD1433 World Class

<< Previous

Bullboard Posts

Next >>

Comment by StevenBirchon Aug 12, 2024 8:30am

156 Views

Post# 36174093

RE:RE:RE:RE:RE:TLD1433 World Class

I hope so Oil, I always thought our life changing news would come in it's own news release and not part of a scheduled update. There can't be much holding them back now.

Oilminerdeluxe wrote: That possible big investor, I hope he gets his/her cash in, asap. Looks like BTD application will be sent in Q3 which we are halfway through. If so, very good. Finally. Just fix some money, Roger.

3 year 33% must be considered good. Sounds like TLT is destroying the competition at the speed of light. Hopefuly more info will follow at the CC in 9 days.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023